FMR CORP 13D and 13G filings for Heron Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2020-07-10 11:38 am Sale |
2020-07-09 | 13G | Heron Therapeutics, Inc. HRTX |
FMR CORP | 1,917,767 2.115% |
-4,664,643 (-70.87%) |
Filing |